# Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

> **NCT00251316** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 34 (actual)

## Conditions studied

- Thyroid Cancer
- Differentiated Thyroid Carcinoma

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00251316
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251316, "Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00251316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*